Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Design, synthesis, and evaluation of novel Indole-Based small molecules as sirtuin inhibitors with anticancer activities.

Binarci B., Kilic E. K., Dogan T., Cetin Atalay R., Kahraman D. C., Nacak Baytas S.
Drug development research , cilt.85, sa.7, 2024 (SCI-Expanded) identifier

Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors

Hawash M., Jaradat N., Abualhasan M., ŞÜKÜROĞLU M. K., Qaoud M. T., KAHRAMAN D. C., et al.
BMC Chemistry , cilt.17, sa.1, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

Novel indole-pyrazole hybrids as potential tubulin-targeting agents; Synthesis, antiproliferative evaluation, and molecular modeling studies

Hawash M., Ergun S. G., KAHRAMAN D. C., OLĞAÇ A., Hamel E., Cetin-Atalay R., et al.
Journal of Molecular Structure , cilt.1285, 2023 (SCI-Expanded) identifier identifier identifier

A new triazolothiadiazine derivative inhibits stemness and induces cell death in HCC by oxidative stress dependent JNK pathway activation

KAHRAMAN D. C., Guven E. B., Aytac P. S., Aykut G., Tozkoparan B., Atalay R. C.
SCIENTIFIC REPORTS , cilt.12, sa.1, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Design and synthesis of novel substituted indole-acrylamide derivatives and evaluation of their anti-cancer activity as potential tubulin-targeting agents

Hawash M., KAHRAMAN D. C., OLĞAÇ A., Ergun S. G., Hamel E., Cetin-Atalay R., et al.
JOURNAL OF MOLECULAR STRUCTURE , cilt.1254, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency

Yilmaz N. S., Eltan S. B., KAYAOĞLU B., Geckin B., Heredia R. J., Sefer A. P., et al.
JOURNAL OF CLINICAL IMMUNOLOGY , cilt.42, sa.3, ss.582-596, 2022 (SCI-Expanded) identifier identifier identifier

Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells.

Narci K., Kahraman D. C., Koyas A., Ersahin T., Tuncbag N., Atalay R. C.
BMC cancer , cilt.22, sa.1, ss.320, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Synthesis of novel indole-isoxazole hybrids and evaluation of their cytotoxic activities on hepatocellular carcinoma cell lines

Hawash M., KAHRAMAN D. C., Ergun S. G., Cetin-Atalay R., BAYTAŞ S.
BMC CHEMISTRY , cilt.15, sa.1, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells

Ibis K., NALBAT E., ÇALIŞKAN B., KAHRAMAN D. C., Cetin-Atalay R., BANOĞLU E.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.221, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation

Hawash M., Kahraman D. C., Cetin-Atalay R., BAYTAŞ S.
CHEMISTRY & BIODIVERSITY , cilt.18, sa.5, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

MDeePred: Novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery

Rifaioglu A., Atalay R. C., KAHRAMAN D. C., DOĞAN T., Martin M., ATALAY M. V.
Bioinformatics , cilt.37, sa.5, ss.693-704, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Transcriptome profiles associated with selenium-deficiency-dependent oxidative stress identify potential diagnostic and therapeutic targets in liver cancer cells

Gozen D., KAHRAMAN D. C., Narci K., Shehwana H., KONU KARAKAYALI Ö., Cetin-Atalay R.
TURKISH JOURNAL OF BIOLOGY , cilt.45, sa.2, ss.149-164, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

CXXC5 as an unmethylated CpG dinucleotide binding protein contributes to estrogen-mediated cellular proliferation.

Ayaz G., Razizadeh N., Yaşar P., Kars G., Kahraman D. C., Saatci Ö., et al.
Scientific reports , cilt.10, ss.5971, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Targeting PI3K/Akt/mTOR Pathway Identifies Differential Expression and Functional Role of IL8 in Liver Cancer Stem Cell Enrichment

KAHRAMAN D. C., Kahraman T., Cetin-Atalay R.
MOLECULAR CANCER THERAPEUTICS , cilt.18, sa.11, ss.2146-2157, 2019 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine-(thio)urea hybrids as potential kinase inhibitors.

Ture A., Kahraman D. C., Cetin-Atalay R., Helvacioglu S., Charehsaz M., KÜÇÜKGÜZEL İ.
Computational biology and chemistry , cilt.78, ss.227-241, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents.

Inceler N., ÖZKAN Y., Turan N. N., Kahraman D. C., Cetin-Atalay R., BAYTAŞ S.
MedChemComm , cilt.9, sa.5, ss.795-811, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics.

Hawash M. M. A., Kahraman D. C., Eren F., Atalay R. C., BAYTAŞ S.
European journal of medicinal chemistry , cilt.129, ss.12-26, 2017 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Quinoides and VEGFR2 TKIs influence the fate of hepatocellular carcinoma and its cancer stem cells.

Kahraman D. C., Hanquet G., Jeanmart L., Lanners S., Sramel P., Bohac A., et al.
MedChemComm , cilt.8, sa.1, ss.81-87, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Phase and TV Based Convex Sets for Blind Deconvolution of Microscopic Images

Tofighi M., Yorulmaz O., Koese K., Yildirim D. C., Cetin-Atalay R., ÇETİN A. E.
IEEE JOURNAL OF SELECTED TOPICS IN SIGNAL PROCESSING , cilt.10, sa.1, ss.81-91, 2016 (SCI-Expanded) Creative Commons License identifier identifier

Ynamide Click chemistry in development of triazole VEGFR2 TK modulators.

Vojtickova M., Dobias J., Hanquet G., Addova G., Cetin-Atalay R., Yildirim D. C., et al.
European journal of medicinal chemistry , cilt.103, ss.105-22, 2015 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Application of the Ugi reaction with multiple amino acid-derived components: synthesis and conformational evaluation of piperazine-based minimalist peptidomimetics.

Stucchi M., Cairati S., Cetin-Atalay R., Christodoulou M. S., Grazioso G., Pescitelli G., et al.
Organic & biomolecular chemistry , cilt.13, sa.17, ss.4993-5005, 2015 (SCI-Expanded) Creative Commons License identifier identifier identifier

Near-IR absorbing BODIPY derivatives as glutathione-activated photosensitizers for selective photodynamic action.

Turan I., Cakmak F., Yildirim D. C., Cetin-Atalay R., Akkaya E.
Chemistry (Weinheim an der Bergstrasse, Germany) , cilt.20, ss.16088-92, 2014 (SCI-Expanded) Creative Commons License identifier identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools

Cetin-Atalay R., Kahraman D. C., Nalbat E., Rifaioğlu A. S., Atakan A., Dönmez A., et al.
JOURNAL OF GASTROINTESTINAL CANCER , cilt.52, sa.4, ss.1266-1276, 2021 (ESCI) identifier identifier identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Targeting sirtuins with novel indole derivatives: implications for anticancer activity in hepatocellular carcinoma

BINARCI B., DOĞAN T., ATALAY R., KAHRAMAN D. C., BAYTAŞ S.
EASL Liver Cancer Summit 2024, Rotterdam, Hollanda, 22 - 24 Şubat 2024

Exploring early markers of fibrosis progression in metabolic dysfunction–associated steatotic liver disease in Turkiye

KAHRAMAN D. C., NALBAT E., ATALAY R., İDİLMAN R.
AASLD-TASL Connect Meeting 2024, İzmir, Türkiye, 16 - 17 Şubat 2024

Repurposing Drugs to Target Molecular Networks in Hepatocellular Carcinoma Cells & Stem Cells for Innovative Treatment Strategies

NALBAT E., TUNÇBAĞ N., KAHRAMAN D. C., ATALAY R.
4th Open Research Day, Türkiye, 01 Aralık 2023

DeepResponse: Large Scale Prediction of Cancer Cell Line Drug Response with Deep Learning Based Pharmacogenomic Modelling

KAHRAMAN D. C., DOĞAN T.
16th International Symposium on Health Informatics and Bioinformatics (HIBIT 2023), Ankara, Türkiye, 4 - 06 Ekim 2023

Anti-Cancer and Anti-Stemness Action of Nonsteroidal Anti-Inflammatory Agents: A Special Focus on Hepatocellular Carcinoma

KAHRAMAN D. C.
3rd International Multidisciplinary Cancer Research Congress, İstanbul, Türkiye, 7 - 10 Eylül 2023

Network-based drug repurposing approach identifies novel drugs and drug combinations against HCC

NALBAT E., TUNÇBAĞ N., KAHRAMAN D. C., ATALAY R.
AASLD-TASL Digital Hepatology Meeting, Ankara, Türkiye, 28 - 29 Nisan 2023

Experimental validation of drug responses predicted by deep learning-based bioactivity models in hepatocellular carcinoma cell lines

KAHRAMAN D. C., DOĞAN T.
15th International Symposium on Health Informatics and Bioinformatics (HIBIT 2022), Mersin, Türkiye, 20 - 22 Ekim 2022

A Multi-Omics and Machine Learning-Based Predictor of Drug Sensitivity in Cancer

KAHRAMAN D. C., DOĞAN T.
15th International Symposium on Health Informatics and Bioinformatics (HIBIT 2022), Mersin, Türkiye, 20 - 22 Ekim 2022

Automated prediction of drug response in HCC cell lines with deep learning-based bioactivity modeling and experimental validation

KAHRAMAN D. C., AKAR E., DOĞAN T.
EACR 2022, Sevilla, İspanya, 20 - 23 Haziran 2022

Synergistic effect of sorafenib in combination with naproxen on hepatocellular carcinoma cell lines

AKAR E., KAHRAMAN D. C.
EACR 2022, Sevilla, İspanya, 20 - 23 Haziran 2022

A NEW THIADIAZINE DERIVATIVE INDUCES OXIDATIVE STRESS DEPENDENT CELL DEATH IN HEPATOCELLULAR CARCINOMA STEM CELLS

KAHRAMAN D. C., GÜVEN E. B., Aytac P., TOZKOPARAN KÖPRÜCÜ B., ATALAY R.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70 identifier

A new thiadiazine derivative induces oxidative stress dependent JNK pathway activation and cell death in hepatocellular carcinoma

KAHRAMAN D. C., GÜVEN E. B., TOZKOPARAN KÖPRÜCÜ B., ATALAY R.
Annual Meeting of the American-Association-for-Cancer-Research (AACR), Georgia, Amerika Birleşik Devletleri, 29 Mart - 03 Nisan 2019, cilt.79 identifier

Abstract 996: In silico modeling and in vitro validation of undefined off-target of drugs in hepatocellular carcinoma

NALBAT E., TUNÇBAĞ N., KAHRAMAN D. C., ATALAY R.
AACR Annual Meeting 2019, Atlanta, Amerika Birleşik Devletleri, 29 Mart - 03 Nisan 2019

In silico modeling and in vitro validation of undefined off-target of drugs in hepatocellular carcinoma

Sinoplu E., Tuncbag N., Kahraman D. C., Atalay R. C.
Annual Meeting of the American-Association-for-Cancer-Research (AACR), Georgia, Amerika Birleşik Devletleri, 29 Mart - 03 Nisan 2019, cilt.79 identifier

Effects of small molecule inhibitors on liver cancer stem cells in comparison with Sorafenib

KAHRAMAN D. C., ATALAY R.
AASLD-TASL Connect Meeting 2019, İstanbul, Türkiye, 15 - 16 Mart 2019

Identification of interleukin 8 as a cancer stem cell enrichment stimulating factor in HCC

KAHRAMAN D. C., ATALAY R.
11th International Symposium on Health Informatics and Bioinformatics (HIBIT 2018), Antalya, Türkiye, 25 - 27 Ekim 2018

Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib

Kahraman D. C., Kahraman T., ATALAY R.
American Association for Cancer Research Annual Meeting 2018, Chicago, Amerika Birleşik Devletleri, 12 - 18 Nisan 2018, cilt.78, ss.3937 Sürdürülebilir Kalkınma

Differential alteration of IL-8 in response to Sorafenib and PI3K/Akt/mTOR inhibitors in liver cancer cells and in liver cancer stem cells

KAHRAMAN D. C., ATALAY R.
AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Philadelphia, Amerika Birleşik Devletleri, 26 - 30 Ekim 2017 identifier

Abstract LB-A08: Differential alteration of IL-8 in response to Sorafenib and PI3K/Akt/mTOR inhibitors in liver cancer cells and in liver cancer stem cells

Kahraman D. C., ATALAY R.
AACR-NCI-EORTC International Conference, Philadelphia, 26 - 30 Ekim 2017 Sürdürülebilir Kalkınma

Potency of Interleukin 8 Blockade in Prevention of Liver Cancer Stem Cell Enrichment

KAHRAMAN D. C., ATALAY R.
5th International BAU Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017

ANTICANCER EFFECTS OF NEW INDOLE –PYRAZOLE AND ONDOLE-OSOXAZOLE HYBRIDS DESIGN, SYNTHESIS AND EVALUATION OF ACTIVITY

Hawash M. M., Kahraman D. C., ATALAY R., BAYTAŞ S.
2nd International Gazi Pharma Symposium, 11 - 13 Ekim 2017

HEPATOCELLULAR CARCİNOMA TERAPEUTICS: SYNTHESIS AND BIOLOGICAL EVALUATION INDOLE-3-CARBOXAMIDES

Kılıç E. K., Kahraman D. C., ATALAY R., BAYTAŞ S.
2nd International Gazi Pharma Symposium, 11 - 13 Ekim 2017

Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation

Hawash M., Kahraman D. C., ATALAY R., BAYTAŞ S.
26th ISHC Congress on Heterocyclic Chemistry, 3 - 08 Eylül 2017

Dielectrophoretic Spectra of CD133+/EpCAM+ HUH7 Cancer Stem Cells and HUH7 Cancer Cells

Çağlayan Z., Demircan Yalçın Y., Özkayar G., Kahraman D. C., Atalay R., Özgür E., et al.
Dielectrophoresis 2016, Massachusetts, Amerika Birleşik Devletleri, 13 - 15 Temmuz 2016, ss.1-4 Sürdürülebilir Kalkınma

Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population

Kahraman D. C., Kahraman T., ATALAY R.
EACR 27, 1 - 04 Temmuz 2016, cilt.61, ss.77 Sürdürülebilir Kalkınma

Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment

KAHRAMAN D. C., ATALAY R.
24th Biennial Congress of the European Association for Cancer Research, Manchester, İngiltere, 9 - 12 Temmuz 2016

Recent Advances in Cancer Stem Cell Research

KAHRAMAN D. C.
COST Action CM1106 4th Workshop, Venedik, İtalya, 10 - 11 Mart 2016

Bioactivities of small molecule kinase inhibitors in liver cancer stem cells

KAHRAMAN D. C., ATALAY R.
COST Action CM1106 3rd Working Group Meeting, ATİNA, Yunanistan, 26 - 27 Mart 2015

Biological Evaluation of New Pyrazole Derivatives for Novel Therapeutic Opportunities of Hepatocellular Carcinoma

KAHRAMAN D. C., BAYTAŞ S., ATALAY R.
MolBiyoKon 2014, İzmir, Türkiye, 10 - 12 Temmuz 2014

Identification of Novel Small Molecule Kinase Inhibitors Against Liver Cancer Stem Cells

KAHRAMAN D. C., ATALAY R.
EACR Sponsored 2nd Anticancer Agents Congress and 5th Multidisciplinary Cancer Research Congress, Muğla, Türkiye, 23 - 25 Nisan 2014

Enrichment of cancer stem cell characteristics of liver cancer cells by prolonged drug selection and identification of cytotoxic activity of new drug candidates

KAHRAMAN D. C., TOZKOPARAN KÖPRÜCÜ B., ATALAY R.
International Multidisciplinary Symposium on Drug Research and Development (DRD2013), Antalya, Türkiye, 28 - 30 Kasım 2013

Metrikler

Yayın

54

Atıf (WoS)

523

H-İndeks (WoS)

14

Atıf (Scopus)

560

H-İndeks (Scopus)

13

Atıf (Scholar)

20

H-İndeks (Scholar)

1

Proje

5

Tez Danışmanlığı

3

Açık Erişim

9
BM Sürdürülebilir Kalkınma Amaçları